Heart Attack Signal Found for Spiriva in COPD
The TIOSPIR trial was used to support safety of the mist inhaler version of tiotropium (Spiriva) compared with dry powder, but the pooled data actually showed something else -- a heart attack signal, researchers argued.
Jan 29, 2014